Diagnosis and Treatment of Polycystic Ovary Syndrome

Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in the all over the world, affecting approximately 6% of female patients. The pathophysiology of the disease is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factors from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Advices from the Endocrine Society mentioned using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries and plus the exclusion of other diagnoses that could result in ovulatory dysfunction.

 

  • Infertility in polycystic ovary syndrome
  • Hyperandrogenism
  • Anovulation
  • Anovulation

Related Conference of Diagnosis and Treatment of Polycystic Ovary Syndrome

July 17-18, 2020

2nd World Conference on Breast and Cervical Cancer

Helsinki, Finland
July 23-24, 2020

International Congress on Reproductive Health and Medicine

Amsterdam, Netherlands
September 09-10, 2020

Global summit on Maternal, Infant and Child Health

Amsterdam, Netherlands
September 09-10, 2020

12th International Conference on Gynecology

Valencia, Spain
October 19-20, 2020

World Congress on Gynecology and Obstetrics

Tokyo, Japan

Diagnosis and Treatment of Polycystic Ovary Syndrome Conference Speakers

Recommended Sessions

Related Journals

Are you interested in